Furuichi Y - Search Results

1

Successful hematopoietic stem cell transplantation from an HLA-mismatched parent for engraftment failure after unrelated cord blood transplantation in patients with juvenile myelomonocytic leukemia: Report of two cases.

Akahane K, Watanabe A, Furuichi Y, Somazu S, Oshiro H, Goi K, Sakashita K, Muramatsu H, Hama A, Takahashi Y, Koike K, Kojima S, Sugita K, Inukai T. Akahane K, et al. Among authors: furuichi y. Pediatr Transplant. 2019 May;23(3):e13378. doi: 10.1111/petr.13378. Epub 2019 Feb 20. Pediatr Transplant. 2019. PMID: 30786117

2

[Prevention of hepatic veno-occlusive disease by a combination of heparin and prostaglandin E1 in children undergoing hematopoietic stem cell transplantation].

Inukai T, Sugita K, Goi K, Akahane K, Hirose K, Nemoto A, Takahashi K, Sato H, Uno K, Furuichi Y, Nakamura M, Miyamoto N, Yamakawa N, Shiraishi K, Kojika S, Tezuka T, Iijima K, Nakazawa S. Inukai T, et al. Among authors: furuichi y. Rinsho Ketsueki. 2004 Apr;45(4):297-303. Rinsho Ketsueki. 2004. PMID: 15168445 Japanese.

3

Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents.

Furuichi Y, Goi K, Inukai T, Sato H, Nemoto A, Takahashi K, Akahane K, Hirose K, Honna H, Kuroda I, Zhang X, Kagami K, Hayashi Y, Harigaya K, Nakazawa S, Sugita K. Furuichi Y, et al. Cancer Res. 2007 Oct 15;67(20):9852-61. doi: 10.1158/0008-5472.CAN-07-0105. Cancer Res. 2007. PMID: 17942916

4

Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression.

Kasai S, Furuichi Y, Ando N, Kagami K, Abe M, Nakane T, Goi K, Inukai T, Saitoh S, Ohno S, Okazaki S, Nagano O, Saya H, Sugita K. Kasai S, et al. Among authors: furuichi y. Cell Death Dis. 2017 Jun 1;8(6):e2857. doi: 10.1038/cddis.2017.249. Cell Death Dis. 2017. PMID: 28569787 Free PMC article.

5

TGFβ1 synergizes with FLT3 ligand to induce chemoresistant quiescence in acute lymphoblastic leukemia with MLL gene rearrangements.

Tamai M, Furuichi Y, Kasai S, Ando N, Harama D, Goi K, Inukai T, Kagami K, Abe M, Ichikawa H, Sugita K. Tamai M, et al. Among authors: furuichi y. Leuk Res. 2017 Oct;61:68-76. doi: 10.1016/j.leukres.2017.08.013. Epub 2017 Sep 14. Leuk Res. 2017. PMID: 28917156

6

Chemosensitivity is differentially regulated by the SDF-1/CXCR4 and SDF-1/CXCR7 axes in acute lymphoblastic leukemia with MLL gene rearrangements.

Ando N, Furuichi Y, Kasai S, Tamai M, Harama D, Kagami K, Abe M, Goi K, Inukai T, Sugita K. Ando N, et al. Among authors: furuichi y. Leuk Res. 2018 Dec;75:36-44. doi: 10.1016/j.leukres.2018.11.001. Epub 2018 Nov 3. Leuk Res. 2018. PMID: 30453100

7

Decreased incidence of acute immune thrombocytopenia in children during the COVID-19 pandemic.

Harama D, Goi K, Saito K, Sato H, Somazu S, Furuichi Y, Takahashi K, Oshiro H, Nakamura M, Sawanobori E, Sato K, Tsuruta M, Murakami Y, Shinohara T, Nemoto A, Kasai S, Tamai M, Watanabe A, Akahane K, Kojika S, Sugita K, Inukai T. Harama D, et al. Among authors: furuichi y. Int J Hematol. 2023 Feb;117(2):307-308. doi: 10.1007/s12185-022-03521-7. Epub 2023 Jan 12. Int J Hematol. 2023. PMID: 36633776 Free PMC article. No abstract available.

8

FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy.

Taketani T, Taki T, Sugita K, Furuichi Y, Ishii E, Hanada R, Tsuchida M, Sugita K, Ida K, Hayashi Y. Taketani T, et al. Among authors: furuichi y. Blood. 2004 Feb 1;103(3):1085-8. doi: 10.1182/blood-2003-02-0418. Epub 2003 Sep 22. Blood. 2004. PMID: 14504097 Free article.

9

Epidemiology of the koch phenomenon of infants after bacillus calmette-Guerin vaccination by interferon-γ release assay status, Japan, 2013-2019.

Ota M, Furuichi Y, Hirao S. Ota M, et al. Among authors: furuichi y. Int J Mycobacteriol. 2023 Jan-Mar;12(1):43-48. doi: 10.4103/ijmy.ijmy_203_22. Int J Mycobacteriol. 2023. PMID: 36926762 Free article.

10

Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management.

Shukla A, Rockey DC, Kamath PS, Kleiner DE, Singh A, Vaidya A, Koshy A, Goel A, Dökmeci AK, Meena B, Philips CA, Sharma CB, Payawal DA, Kim DJ, Lo GH, Han G, Qureshi H, Wanless IR, Jia J, Sollano JD, Al Mahtab M, Muthiah MD, Sonderup MW, Nahum MS, Merican MIB, Ormeci N, Kawada N, Reddy R, Dhiman RK, Gani R, Hameed SS, Harindranath S, Jafri W, Qi X, Chawla YK, Furuichi Y, Zheng MH, Sarin SK. Shukla A, et al. Among authors: furuichi y. Hepatol Int. 2024 Dec;18(6):1684-1711. doi: 10.1007/s12072-024-10739-6. Epub 2024 Nov 15. Hepatol Int. 2024. PMID: 39546143 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters